Skip to content

Organon logo

Main menu
      • Our focus
      • Products list
      • Patient support programs
      • Organon Pro for healthcare professionals
      • Safety data sheets
      • Product patents
      • Leadership team
      • Board of Directors
      • Corporate governance
    • Business development
    • Our culture
    • Our stories
    • Policies & positions
    • Environmental, social & governance
      • Our Suppliers
      • Supplier relationship management
    • Media
    • News
    • Investor relations overview
    • Events & presentations
    • SEC filings
    • Financial Information
    • Investor resources
  • Careers

Contact us

Visit Organon's Twitter Opens a new window Visit Organon's Facebook Opens a new window Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

Speaking their language: engaging teens on sexual and reproductive health

Organon’s grant to FAQ is using social media to reach young people on important topics like contraception

April 12, 2024

Share this article

Her Plan is Her Power is Organon’s three-year, $30 million commitment to drive global action and community-led responses to reduce unplanned pregnancies and empower women and girls when it comes to their sexual and reproductive health. As part of this initiative, the Her Promise grants program is enabling local responses around the world like this one, based on the unique geographic, cultural and institutional factors of each area. Together, these efforts are helping realize Organon’s goal to help prevent 120 million unplanned pregnancies globally by 2030.

Educating teenagers, especially on complex topics like sexual and reproductive health, can be a challenge. Often, it is not as much about the message as it is the messenger. Finding ways to meet teens where they are – on social media, mainly – is critical. That’s the idea behind F/A/Q – The Better Health Group’s initiative.

FAQ The Better Health Group initiative.  Students in South Africa are using social media to discuss sexual and reproductive health topics like contraception.

Called FAQ for short, the program is a pilot exploring the use of social media channels to educate teens in Germany and South Africa on sexual and reproductive health topics like contraception. In part thanks to a Her Promise grant from Organon, the initiative is discovering that using provocative images and terms – talking like a teen – is key to success.

“This program proves that young people should be the spokespeople to young people,” says Jan Weissflog, Organon’s Director, Market Access, Policy & Communications, DACH cluster.

Speaking the right language

Information on contraception is a critical need. As Bongwie Ndlovu, a Project Manager for FAQ in South Africa explains, there is still a stigma about discussing sexual and reproductive health with young people, in developed and developing countries alike.

The organization’s FAQ channel on TikTok is one of the most influential accounts in Central Europe, with more than 400,000 followers and over 43 million views. With Organon’s support, they’ve added e-learning content on contraception, including a tool to help young women select the best contraception method for them. And in South Africa, radio ads are reaching youth.

FAQ The Better Health Group initiative.  Students in Germany are using social media to discuss sexual and reproductive health topics like contraception.

“If we are willing to rephrase sexual health for young people and align with how they speak in popular culture, their receptiveness to the information is much better,” she notes.

Proven results

Between May and August 2023, FAQ’s content in Germany reached more than 30,000 people on Tik Tok. There were more than 175,000 engagements on the contraceptive content alone.

“If we are willing to rephrase sexual health for young people and align with how they speak in popular culture, their receptiveness to the information is much better.”

Bongwie Ndlovu, Project Manager, FAQ

And in South Africa, the added radio ads with FAQ content reached more than 1.5 million listeners through August 2023.

“It’s all about packaging the information in a way that is palatable for teens,” emphasizes Jan. “FAQ’s unique, thought-provoking approach is working and we’re proud to be part of their success.”

Explore more in

Her Promise

Connect with us on social

Linkedin icon Opens a new window Twitter icon Opens a new window Facebook icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
Organon logo

Company

  • About us
  • Our Leaders
  • Environmental, social & governance
  • Policies & positions

Resources

  • Patient resources
  • Investor relations
  • Media
  • Organon Pro for healthcare professionals

Contact us

  • Contact information
  • Global locations
  • Forward-Looking Statement
  • Cookie policy
  • Privacy Policy
  • Consumer Health Data Policy
  • Terms of Use
  • Sitemap
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies. This site is intended for residents of the United States.
Level Access website accessibility icon. Opens a new window TRUSTe Opens a new window

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

Any statements set forth on this website that are not historical facts are considered “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of Organon’s management and are subject to significant risks and uncertainties. By their nature, forward-looking statements involve risks and uncertainties because they depend on circumstances that may or may not occur in the future. Although these statements are based on assumptions that we believe are reasonable when made, we caution you that forward-looking statements are not guarantees of future performance and you should not place undue reliance on them.

Organon undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s other filings with the Securities and Exchange Commission (SEC), including its registration statement on Form 10, available at the SEC’s Internet site (www.sec.gov Opens a new window).

Decline Accept